Nancy Tricoche

1.5k total citations
27 papers, 824 citations indexed

About

Nancy Tricoche is a scholar working on Infectious Diseases, Epidemiology and Parasitology. According to data from OpenAlex, Nancy Tricoche has authored 27 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 8 papers in Epidemiology and 7 papers in Parasitology. Recurrent topics in Nancy Tricoche's work include Parasitic Diseases Research and Treatment (15 papers), Hepatitis B Virus Studies (7 papers) and Parasites and Host Interactions (7 papers). Nancy Tricoche is often cited by papers focused on Parasitic Diseases Research and Treatment (15 papers), Hepatitis B Virus Studies (7 papers) and Parasites and Host Interactions (7 papers). Nancy Tricoche collaborates with scholars based in United States, Liberia and Cameroon. Nancy Tricoche's co-authors include Sara Lustigman, Alfred M. Prince, Marion E. Perkus, Betsy Brotman, Mohamed Tarek M. Shata, Kim D. Janda, Wolfram Pfahler, Preeti Pancholi, Qingyan Liu and Linda Andrus and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Virology.

In The Last Decade

Nancy Tricoche

26 papers receiving 803 citations

Peers

Nancy Tricoche
Ming Qiao Australia
Andrew Tuplin United Kingdom
Fadi Saadé Australia
Obeid E. Obeid United Kingdom
Hugh Maguire United States
Larry G. Birkenmeyer United States
Gavan Holloway Australia
Ming Qiao Australia
Nancy Tricoche
Citations per year, relative to Nancy Tricoche Nancy Tricoche (= 1×) peers Ming Qiao

Countries citing papers authored by Nancy Tricoche

Since Specialization
Citations

This map shows the geographic impact of Nancy Tricoche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Tricoche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Tricoche more than expected).

Fields of papers citing papers by Nancy Tricoche

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Tricoche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Tricoche. The network helps show where Nancy Tricoche may publish in the future.

Co-authorship network of co-authors of Nancy Tricoche

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Tricoche. A scholar is included among the top collaborators of Nancy Tricoche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Tricoche. Nancy Tricoche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Voronin, Denis, Nancy Tricoche, Anna Kamińska, et al.. (2024). Repurposed Drugs That Activate Autophagy in Filarial Worms Act as Effective Macrofilaricides. Pharmaceutics. 16(2). 256–256.
2.
Bryant, Clifford, Christina A. Bulman, Ian Vogel, et al.. (2022). Pyrvinium Pamoate and Structural Analogs Are Early Macrofilaricide Leads. Pharmaceuticals. 15(2). 189–189. 2 indexed citations
3.
Jawahar, S, Nancy Tricoche, Christina A. Bulman, Judy A. Sakanari, & Sara Lustigman. (2021). Drugs that target early stages of Onchocerca volvulus: A revisited means to facilitate the elimination goals for onchocerciasis. PLoS neglected tropical diseases. 15(2). e0009064–e0009064. 10 indexed citations
4.
Luchsinger, Larry L., Frauke Muecksch, Yiska Weisblum, et al.. (2020). Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients. Journal of Clinical Microbiology. 58(12). 101 indexed citations
6.
Voronin, Denis, Nancy Tricoche, S Jawahar, et al.. (2019). Development of a preliminary in vitro drug screening assay based on a newly established culturing system for pre-adult fifth-stage Onchocerca volvulus worms. PLoS neglected tropical diseases. 13(1). e0007108–e0007108. 23 indexed citations
7.
George, Parakkal Jovvian, Jessica A. Hess, Sonia Jain, et al.. (2019). Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans. PLoS neglected tropical diseases. 13(9). e0007730–e0007730. 14 indexed citations
8.
Zhan, Bin, Malcolm W. Kennedy, Nancy Tricoche, et al.. (2018). Ligand binding properties of two Brugia malayi fatty acid and retinol (FAR) binding proteins and their vaccine efficacies against challenge infection in gerbils. PLoS neglected tropical diseases. 12(10). e0006772–e0006772. 16 indexed citations
9.
Chen, Wen‐Hsiang, Lanying Du, Cuiqing Ma, et al.. (2013). Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate. Human Vaccines & Immunotherapeutics. 10(3). 648–658. 80 indexed citations
10.
Lopez-Perez, Mary, Katherine Torres, Dionicia Gamboa, et al.. (2012). Anti-Plasmodium falciparum invasion ligand antibodies in a low malaria transmission region, Loreto, Peru. Malaria Journal. 11(1). 361–361. 26 indexed citations
11.
Wang, Jing, Nancy Tricoche, Lanying Du, et al.. (2012). The Adjuvanticity of an O. volvulus-Derived rOv-ASP-1 Protein in Mice Using Sequential Vaccinations and in Non-Human Primates. PLoS ONE. 7(5). e37019–e37019. 27 indexed citations
12.
Garner, Amanda L., Christian Johannes Gloeckner, Nancy Tricoche, et al.. (2011). Design, Synthesis, and Biological Activities of Closantel Analogues: Structural Promiscuity and Its Impact on Onchocerca volvulus. Journal of Medicinal Chemistry. 54(11). 3963–3972. 24 indexed citations
13.
Hu, Yu‐Wen, Nancy Tricoche, Wolfram Pfahler, et al.. (2008). Evidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia Virus. Journal of Virology. 82(21). 10896–10905. 44 indexed citations
14.
Shata, Mohamed Tarek M., Wolfram Pfahler, Betsy Brotman, et al.. (2006). Attempted therapeutic immunization in a chimpanzee chronic HBV carrier with a high viral load. Journal of Medical Primatology. 35(3). 165–171. 13 indexed citations
15.
Prince, Alfred M., Betsy Brotman, Dong Hun Lee, et al.. (2005). Protection against Chronic Hepatitis C Virus Infection after Rechallenge with Homologous, but Not Heterologous, Genotypes in a Chimpanzee Model. The Journal of Infectious Diseases. 192(10). 1701–1709. 63 indexed citations
16.
Shata, Mohamed Tarek M., Nancy Tricoche, Marion E. Perkus, et al.. (2003). Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees. Virology. 314(2). 601–616. 68 indexed citations
17.
Shata, Mohamed Tarek M., et al.. (2003). Optimization of recombinant vaccinia-based ELISPOT assay. Journal of Immunological Methods. 283(1-2). 281–289. 5 indexed citations
18.
Shata, Mohamed Tarek M., Donald D. Anthony, Linda Andrus, et al.. (2002). Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees. Journal of Viral Hepatitis. 9(6). 400–410. 36 indexed citations
20.
Pancholi, Preeti, Qingyan Liu, Nancy Tricoche, et al.. (2000). DNA Prime–Canarypox Boost with Polycistronic Hepatitis C Virus (HCV) Genes Generates Potent Immune Responses to HCV Structural and Nonstructural Proteins. The Journal of Infectious Diseases. 182(1). 18–27. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026